Advertisement

New Standard Helps Ensure Accurate Clinical Measurements of HER2 Breast Cancer Gene

A new measurement standard developed by the National Institute of Standards of Technology (NIST) has been used successfully by the Frederick National Laboratory for Cancer Research to check the performance of next-generation DNA-sequencing technologies for evaluating gene variations associated with an increased risk of breast cancer.

 Science Daily

click me